Radiofrequency ablation (RFA) is one of the most promising ablative techniques for BE. The technique uses a bipolar electrode that is available as a balloon-based device for primary circumferential ablation or as a cap-based device that can be mounted on the tip of the endoscope for focal ablation.
The key factors that boost the growth of the global endoscope + radiofrequency ablation (RFA) market include upsurge in demand for novel treatment methods for patients suffering from cancer, cardiovascular diseases, and disorders associated with chronic pain along with the benefits offered by this advanced treatment modality. Several research studies have concluded that radiofrequency ablation (RFA) treatment efficiently creates lesion in the targeted body parts while maintaining short procedure durations.
In 2018, the global Endoscope + Radiofrequency Ablation (RFA) market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Endoscope + Radiofrequency Ablation (RFA) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Endoscope + Radiofrequency Ablation (RFA) development in United States, Europe and China.
The key players covered in this study
Boston Scientific Corporation Conmed Corporation
Medtronic Plc (Covidien Plc)
Smith & Nephew Plc
Stryker Corporation
Halyard Health
Abbott Laboratories (St. Jude Medical, Inc.)
AngioDynamics
Hologic
AtriCure
Market segment by Type, the product can be split into
Focal Ablation
Others
Market segment by Application, split into
Cardiology Application
Pain Management
Oncology Application
Other Application
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Endoscope + Radiofrequency Ablation (RFA) status, future forecast, growth opportunity, key market and key players.
To present the Endoscope + Radiofrequency Ablation (RFA) development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Endoscope + Radiofrequency Ablation (RFA) are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Summary:
Get latest Market Research Reports on Endoscope + Radiofrequency Ablation (RFA) . Industry analysis & Market Report on Endoscope + Radiofrequency Ablation (RFA) is a syndicated market report, published as Global Endoscope + Radiofrequency Ablation (RFA) Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Endoscope + Radiofrequency Ablation (RFA) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.